Based on this result, we suggest that APOE genotyping can be added to the items of newborn screening programs to detect infants with a high risk of Alzheimer’s disease, cardiovascular diseases, and type 2 diabetes. The gene discussed is APOE; the disease is type 2 diabetes mellitus.